Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Ono researchers develop novel chemokine CCR5 antagonists

Nov. 4, 2004

Millennium presents new ALK5 inhibitors and their potential applications

Nov. 4, 2004

Novel 5-HT6 receptor ligands designed by GSK scientists

Nov. 4, 2004

Two series of MCH receptor antagonists developed at Neurocrine

Nov. 4, 2004

New factor XIa inhibitors identified by BMS researchers

Nov. 3, 2004

New Chk1 kinase inhibitors under study at Abbott

Nov. 3, 2004

New phenylsulfonamide-based gamma-secretase inhibitors and their use in AD

Nov. 3, 2004

New factor Xa inhibitors in early development at Boehringer Ingelheim

Nov. 3, 2004

New CD80 antagonists and their use claimed by Avidex

Nov. 3, 2004

New vitamin D analogues and their use in bone diseases, cancer, etc.

Nov. 3, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...